Distinguished Orthopaedic Surgeon Joins NeoStem’s Medical Advisory Board
NeoStem, Inc. (“NeoStem”) recently announced the appointment of Thomas Einhorn, M.D., Chairman of Orthopaedic Surgery at Boston University to its Medical Advisory Board. NeoStem is an international biopharmaceutical company that is engaged in the development of stem cell-based therapies and building a network of adult stem cell collection centers in the United States and China that allow people to donate and store their own stem cells for their personal use in the event of a future medical need. Dr. Einhorns professional focus has been on the repair and regeneration of bone and cartilage using autologous adult stem cells, reconstructive surgery of the hip and knee, and the treatment of metabolic bone disease making him an excellent addition to NeoStems Medical Advisory Board.
Dr. Einhorn is Chairman of the Department of Orthopaedic Surgery and Professor of Orthopaedic Surgery, Biochemistry and Biomedical Engineering at Boston University. To date, he has authored over 200 peer-reviewed articles during his career. Dr. Einhorn has a distinguished career which includes serving as Chairman and President of numerous orthopaedic research societies and foundations. In addition, he has won numerous awards and served as Deputy Editor for Current Concepts Reviews for The Journal of Bone and Joint Surgery, and on the Editorial Boards of The Journal of Bone and Mineral Research, Journal of Orthopaedic Research and Bone.
Wayne A. Marasco, M.D., Ph.D., Chairman of NeoStems Advisory Boards, stated, “We are extremely pleased to have Dr. Einhorn join our medical advisory board. His in-depth understanding of orthopaedic injuries and the use of adult stem cells to regenerate damaged bone and cartilage will be a tremendous asset in our development of applications of adult stem cells for orthopedic injuries.”
Dr. Einhorn stated, “I am excited to join the Medical Advisory Board of an innovative, forward-looking company like NeoStem and be part of the team of experts to help advance stem cell technologies in the field of orthopaedics and assist in developing VSEL┞¢ Technology applications for orthopaedic disease. Not only has [NeoStem] put together a promising base of technologies for future stem cell treatment in orthopaedics, cardiac, skin rejuvenation and the treatment of wounds but it continues to partner with experts in other areas to facilitate meaningful [Research and Development]. This should encourage people to collect, process, and store their stem cells through NeoStems existing network of collection centers in anticipation of a variety of future personalized medicine applications.”